Eflornithine

Drug Details

Vaniqa, containing the active ingredient eflornithine, is a prescription cream specifically designed for women to manage unwanted facial hair growth. It is applied to the face and under the chin, working by inhibiting the enzyme ornithine decarboxylase (ODC) in the skin, which is essential for hair growth. By reducing the activity of this enzyme, the cream effectively slows down hair growth, resulting in finer and lighter hair. It is important to note that Vaniqa does not remove existing hair but only reduces the rate of new hair growth. Application should be carried out twice daily, with a minimum interval of 8 hours between uses. Possible side effects include acne and a stinging sensation on the skin. This medication is not suitable for children under the age of 12. Although Vaniqa was discontinued in 2023, an alternative product with the same active ingredient, Florexa, is available for use. Always consult with healthcare professionals before starting any new treatment.